TR199900956T2 - S�bstit�e edilmi� trisiklik bile�imler. - Google Patents
S�bstit�e edilmi� trisiklik bile�imler.Info
- Publication number
- TR199900956T2 TR199900956T2 TR1999/00956T TR9900956T TR199900956T2 TR 199900956 T2 TR199900956 T2 TR 199900956T2 TR 1999/00956 T TR1999/00956 T TR 1999/00956T TR 9900956 T TR9900956 T TR 9900956T TR 199900956 T2 TR199900956 T2 TR 199900956T2
- Authority
- TR
- Turkey
- Prior art keywords
- tricyclic
- edilmi
- bstit
- imler
- bile
- Prior art date
Links
- 210000000941 bile Anatomy 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000005473 Secretory Phospholipases A2 Human genes 0.000 abstract 1
- 108010031873 Secretory Phospholipases A2 Proteins 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Fats And Perfumes (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2984996P | 1996-10-30 | 1996-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199900956T2 true TR199900956T2 (xx) | 1999-07-21 |
Family
ID=21851210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1999/00956T TR199900956T2 (xx) | 1996-10-30 | 1997-10-23 | S�bstit�e edilmi� trisiklik bile�imler. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0839806B1 (https=) |
| JP (1) | JP2001503055A (https=) |
| KR (1) | KR20000049210A (https=) |
| CN (1) | CN1233176A (https=) |
| AR (1) | AR010050A1 (https=) |
| AT (1) | ATE244703T1 (https=) |
| AU (1) | AU734096B2 (https=) |
| BR (1) | BR9713261A (https=) |
| CA (1) | CA2269203A1 (https=) |
| CO (1) | CO4920250A1 (https=) |
| CZ (1) | CZ136899A3 (https=) |
| DE (1) | DE69723393T2 (https=) |
| DK (1) | DK0839806T3 (https=) |
| EA (1) | EA003992B1 (https=) |
| ES (1) | ES2202560T3 (https=) |
| ID (1) | ID18685A (https=) |
| IL (1) | IL129481A0 (https=) |
| NO (1) | NO314899B1 (https=) |
| NZ (1) | NZ335246A (https=) |
| PE (1) | PE10999A1 (https=) |
| PL (1) | PL332896A1 (https=) |
| PT (1) | PT839806E (https=) |
| TR (1) | TR199900956T2 (https=) |
| TW (1) | TW513428B (https=) |
| WO (1) | WO1998018464A1 (https=) |
| YU (1) | YU19299A (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2301586A1 (en) * | 1997-08-28 | 1999-03-04 | William Louis Macias | Method for treatment of non-rheumatoid arthritis |
| HUP0102981A3 (en) | 1998-03-31 | 2002-10-28 | Shionogi & Co | Pyrrolo[1,2-a]pyrazine derivatives and pharmaceutical compositions thereof |
| IL129484A0 (en) * | 1998-04-17 | 2000-02-29 | Lilly Co Eli | Substituted tricyclics |
| DZ2769A1 (fr) * | 1998-04-17 | 2003-12-01 | Lilly Co Eli | Composés tricycliques substitués. |
| BR9910095A (pt) | 1998-05-01 | 2000-12-26 | Lilly Co Eli | Compostos inibidores de spla2 para tratamento de doença |
| WO1999059999A1 (en) | 1998-05-21 | 1999-11-25 | Shionogi & Co., Ltd. | PYRROLO[1,2-b]PYRIDAZINE DERIVATIVES HAVING sPLA2 INHIBITORY EFFECT |
| AU6004799A (en) | 1998-10-14 | 2000-05-01 | Shionogi & Co., Ltd. | Remedies or preventives for ischemic reflow failure |
| US6448284B1 (en) * | 1998-12-22 | 2002-09-10 | Eli Lilly And Company | Substituted tricyclics |
| AU6015600A (en) | 1999-07-19 | 2001-02-05 | Shionogi & Co., Ltd. | Tricyclic compounds having spla2-inhibitory activities |
| US6673781B1 (en) | 1999-08-02 | 2004-01-06 | Shionogi & Co., Ltd. | Tricyclic compounds having sPLA2-inhibitory activities |
| WO2001014378A1 (en) | 1999-08-23 | 2001-03-01 | Shionogi & Co., Ltd. | PYRROLOTRIAZINE DERIVATIVES HAVING sPLA2-INHIBITORY ACTIVITIES |
| MY125942A (en) | 1999-09-07 | 2006-09-29 | Upjohn Co | Aminoalkoxy carbazoles for the treatment of cns diseases |
| US6756376B1 (en) | 1999-11-15 | 2004-06-29 | Shionogi & Co., Ltd. | Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities |
| JP2003519198A (ja) * | 2000-01-06 | 2003-06-17 | イーライ・リリー・アンド・カンパニー | 炎症性疾患および呼吸器疾患の処置のための併用療法 |
| US6967200B2 (en) | 2000-06-29 | 2005-11-22 | Shionogi & Co., Ltd. | Remedies for cirrhosis |
| WO2002000621A1 (en) | 2000-06-29 | 2002-01-03 | Shionogi & Co., Ltd. | Compounds exhibiting x-type spla2 inhibiting effect |
| EP1345898A2 (en) | 2000-12-18 | 2003-09-24 | Eli Lilly And Company | Teracyclic carbazole derivates and their use as spla2 inhibitors |
| TWI314457B (https=) * | 2001-03-19 | 2009-09-11 | Shionogi & Co | |
| AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
| WO2006046779A1 (ja) | 2004-10-29 | 2006-05-04 | Zeria Pharmaceutical Co., Ltd. | カルバゾール誘導体、その溶媒和物、又は薬学的に許容されるその塩 |
| WO2016203468A1 (en) * | 2015-06-15 | 2016-12-22 | Raziel Therapeutics Ltd. | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof |
| CN112409493B (zh) * | 2020-08-12 | 2022-09-30 | 浙江工业大学 | 一种重组融合酶及其在乙醛酸甲酯合成中的应用 |
| US12208031B2 (en) | 2020-10-21 | 2025-01-28 | Purewick Corporation | Adapters for fluid collection devices |
| US12440370B2 (en) | 2020-10-21 | 2025-10-14 | Purewick Corporation | Apparatus with compressible casing for receiving discharged urine |
| US12257174B2 (en) | 2020-10-21 | 2025-03-25 | Purewick Corporation | Fluid collection assemblies including at least one of a protrusion or at least one expandable material |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3479391A (en) * | 1966-10-03 | 1969-11-18 | Squibb & Sons Inc | Delta**3,14-17alpha-hydroxy-norprogesterone and esters |
| US3979391A (en) * | 1972-11-22 | 1976-09-07 | Sterling Drug Inc. | 1,2,3,4-Tetrahydrocarbazoles |
| US3939177A (en) * | 1972-11-22 | 1976-02-17 | Sterling Drug Inc. | 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles |
| US5420289A (en) * | 1989-10-27 | 1995-05-30 | American Home Products Corporation | Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase |
| IL109309A (en) * | 1993-04-16 | 2000-06-29 | Lilly Co Eli | 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them |
| IL109311A0 (en) * | 1993-04-16 | 1994-07-31 | Lilly Co Eli | 1H-indole-3-acetamide sPla2 inhibitors |
-
1997
- 1997-10-23 CA CA002269203A patent/CA2269203A1/en not_active Abandoned
- 1997-10-23 JP JP10520585A patent/JP2001503055A/ja active Pending
- 1997-10-23 YU YU19299A patent/YU19299A/sh unknown
- 1997-10-23 NZ NZ335246A patent/NZ335246A/en unknown
- 1997-10-23 BR BR9713261-6A patent/BR9713261A/pt unknown
- 1997-10-23 TR TR1999/00956T patent/TR199900956T2/xx unknown
- 1997-10-23 CZ CZ991368A patent/CZ136899A3/cs unknown
- 1997-10-23 CN CN97198834A patent/CN1233176A/zh active Pending
- 1997-10-23 EA EA199900305A patent/EA003992B1/ru not_active IP Right Cessation
- 1997-10-23 WO PCT/US1997/019183 patent/WO1998018464A1/en not_active Ceased
- 1997-10-23 AU AU51494/98A patent/AU734096B2/en not_active Ceased
- 1997-10-23 PL PL97332896A patent/PL332896A1/xx unknown
- 1997-10-23 KR KR1019990703309A patent/KR20000049210A/ko not_active Ceased
- 1997-10-23 IL IL12948197A patent/IL129481A0/xx unknown
- 1997-10-24 PE PE1997000950A patent/PE10999A1/es not_active Application Discontinuation
- 1997-10-27 ID IDP973534A patent/ID18685A/id unknown
- 1997-10-28 AR ARP970104997A patent/AR010050A1/es active IP Right Grant
- 1997-10-28 CO CO97063171A patent/CO4920250A1/es unknown
- 1997-10-29 AT AT97308645T patent/ATE244703T1/de active
- 1997-10-29 DK DK97308645T patent/DK0839806T3/da active
- 1997-10-29 ES ES97308645T patent/ES2202560T3/es not_active Expired - Lifetime
- 1997-10-29 DE DE69723393T patent/DE69723393T2/de not_active Expired - Lifetime
- 1997-10-29 PT PT97308645T patent/PT839806E/pt unknown
- 1997-10-29 EP EP97308645A patent/EP0839806B1/en not_active Expired - Lifetime
- 1997-10-30 TW TW086116217A patent/TW513428B/zh not_active IP Right Cessation
-
1999
- 1999-04-16 NO NO19991831A patent/NO314899B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69723393T2 (de) | 2004-06-09 |
| DK0839806T3 (da) | 2003-10-27 |
| EP0839806A1 (en) | 1998-05-06 |
| EA003992B1 (ru) | 2003-12-25 |
| CN1233176A (zh) | 1999-10-27 |
| EP0839806B1 (en) | 2003-07-09 |
| BR9713261A (pt) | 2000-03-28 |
| NO314899B1 (no) | 2003-06-10 |
| AU5149498A (en) | 1998-05-22 |
| YU19299A (sh) | 2000-03-21 |
| DE69723393D1 (de) | 2003-08-14 |
| AR010050A1 (es) | 2000-05-17 |
| CA2269203A1 (en) | 1998-05-07 |
| CZ136899A3 (cs) | 1999-09-15 |
| ID18685A (id) | 1998-04-30 |
| EA199900305A1 (ru) | 1999-12-29 |
| ATE244703T1 (de) | 2003-07-15 |
| AU734096B2 (en) | 2001-06-07 |
| JP2001503055A (ja) | 2001-03-06 |
| WO1998018464A1 (en) | 1998-05-07 |
| NZ335246A (en) | 2001-09-28 |
| TW513428B (en) | 2002-12-11 |
| CO4920250A1 (es) | 2000-05-29 |
| PL332896A1 (en) | 1999-10-25 |
| PE10999A1 (es) | 1999-02-10 |
| NO991831L (no) | 1999-06-21 |
| ES2202560T3 (es) | 2004-04-01 |
| NO991831D0 (no) | 1999-04-16 |
| KR20000049210A (ko) | 2000-07-25 |
| IL129481A0 (en) | 2000-02-29 |
| PT839806E (pt) | 2003-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199900956T2 (xx) | S�bstit�e edilmi� trisiklik bile�imler. | |
| TR199900853A2 (xx) | S�bstit�e edilmi� trisiklik bile�ikler. | |
| TR199900842A2 (xx) | S�bstit�e edilmi� trisiklik bile�ikler. | |
| ES2155601T3 (es) | Compuestos de benzolactama sustituidos como antagonistas de la sustancia p. | |
| ES2111712T3 (es) | Compuestos inhibidores de doble efecto. | |
| SE9903594D0 (sv) | Cationic polymers for sludge dewatering | |
| FI943542A0 (fi) | Trisyklisiä bentsatsepiineja, jotka ovat vasopressiiniantagonisteja | |
| PL319605A1 (en) | Novel benzoxazoles | |
| GT199900055A (es) | Nuevas dihidropirimidinas2 heterocìclicamente sustituidas. | |
| BR9714002A (pt) | Pirróis como inibidores de spla2 | |
| BR9914380A (pt) | Processos para prevenir ou tratar condição prurìtica vaginal em um mamìfero, e, para prevenir ou tratar condição prurìtica nas áreas procto-uro-genital de um mamìfero | |
| ES2183340T3 (es) | Procedimiento para la preparcion de compuestos de 4-bromometil-bifenilo. | |
| ES2187738T3 (es) | Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen. | |
| AR006058A1 (es) | Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido | |
| ES2159347T3 (es) | Naftil-acetamidas como inhibidores de spla2. | |
| AR000813A1 (es) | Procedimiento para la obtencion de n-aril y n-heteroarilhidroxilaminas | |
| FR2379581A1 (fr) | Colorants fluorescents derives de la coumarine | |
| ATE233484T1 (de) | Desinfizierende zusammensetzung | |
| MX9305093A (es) | Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa. | |
| AR005619A1 (es) | Procedimiento para preparar compuestos dicetonicos | |
| ES8705421A1 (es) | Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas | |
| ES2174034T3 (es) | Naftilglioxamidas como inhibidores de spla2 | |
| CO5160271A1 (es) | Composicion de alta pureza que comprende (7 alfa, 17 alfa)- 17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona | |
| ES2104174T3 (es) | Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos. | |
| DE69910432D1 (de) | Substituierte pyrroloindole |